Vimian Group AB (publ) (VIMGF)

OTCMKTS · Delayed Price · Currency is USD
3.990
0.00 (0.00%)
At close: Jun 23, 2025
48.88%
Market Cap 2.20B
Revenue (ttm) 422.61M
Net Income (ttm) 20.86M
Shares Out n/a
EPS (ttm) 0.04
PE Ratio 105.64
Forward PE 32.27
Dividend n/a
Ex-Dividend Date n/a
Volume 1,190
Average Volume 5,764
Open 3.990
Previous Close n/a
Day's Range 3.990 - 3.990
52-Week Range 3.150 - 4.500
Beta 1.56
RSI 49.38
Earnings Date Jul 18, 2025

About Vimian Group AB

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the I... [Read more]

Sector Healthcare
Founded 2020
Employees 1,200
Stock Exchange OTCMKTS
Ticker Symbol VIMGF
Full Company Profile

Financial Performance

In 2024, Vimian Group AB's revenue was 374.80 million, an increase of 12.99% compared to the previous year's 331.70 million. Earnings were 18.50 million, an increase of 88.78%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.